{
  "@context": {
    "biotools": "https://bio.tools/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://bio.tools/simexpr2sampledata",
      "@type": "sc:SoftwareApplication",
      "biotools:primaryContact": "Barbara Di Camillo",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalTool/0.6-DRAFT",
      "sc:additionalType": "Command-line tool",
      "sc:applicationSubCategory": {
        "@id": "edam:topic_3307"
      },
      "sc:citation": {
        "@id": "https://doi.org/10.1371/journal.pone.0032200"
      },
      "sc:description": "Methodologies for the discovery of biomarkers related to diseases using microarray data often provide limited results, due to the dataset size, the heterogeneity of the disease and the heterogeneity of experimental protocols and computational pipelines employed in the analysis. Focusing on the first two issues, a simulation schema was developed to outline advantages and drawbacks of classification and feature selection methods on a benchmark with known biomarkers.",
      "sc:featureList": {
        "@id": "edam:operation_3566"
      },
      "sc:name": "SimExpr2SampleData",
      "sc:operatingSystem": [
        "Windows",
        "Mac",
        "Linux"
      ],
      "sc:provider": "ELIXIR-ITA-PADOVA",
      "sc:softwareHelp": {
        "@id": "http://sysbiobig.dei.unipd.it/?q=Software#SimExpr2SampleData"
      },
      "sc:softwareVersion": "1.0",
      "sc:url": "http://sysbiobig.dei.unipd.it/?q=Software#SimExpr2SampleData"
    },
    {
      "@id": "https://doi.org/10.1371/journal.pone.0032200",
      "@type": "sc:CreativeWork"
    }
  ]
}